Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status

INTRODUCTION: We evaluated for two novel automated biomarker assays how cerebrospinal fluid (CSF) amyloid beta (Aβ)(1– 42)‐ratios improved the concordance with amyloid positron emission tomography (PET) positivity compared to Aβ(1– 42) alone. METHODS: We selected 288 individuals from the Amsterdam D...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Alzheimers Dement (Amst)
Main Authors: Willemse, Eline A. J., Tijms, Betty M., van Berckel, Bart N. M., Le Bastard, Nathalie, van der Flier, Wiesje M., Scheltens, Philip, Teunissen, Charlotte E.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2021
Assuntos:
Cerebrospinal Fluid Biomarkers
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8088096/
https://ncbi.nlm.nih.gov/pubmed/33969174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dad2.12182
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares